Get informed when a big investor buys or sells
+ FollowOvervalued by 68.5% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $28.70 Billion |
|---|---|
| Enterprise Value | $28.38 Billion |
| Annual dividend | $0.46 |
| Dividend yield | 1.13% |
| Earnings per Share | $0.81 |
| Beta | 0.89 |
| Outstanding Shares | 586,936,828 |
| P/E Ratio | 61.09 |
|---|---|
| PEG | -192.28 |
| Price to Sales | 4.01 |
| Price to Book Ratio | 9.36 |
| Enterprise Value to Revenue | 6.21 |
| Enterprise Value to EBIT | 20.41 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Fisher & Paykel Healthcare Corporation Limited, operating with its various subsidiaries, is a global innovator in medical device technology. The company specializes in the design, production, and worldwide distribution of sophisticated p...